Advertisement
Advertisement
U.S. markets close in 6 hours 13 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NGM Biopharmaceuticals, Inc. (NGM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
5.47-0.12 (-2.15%)
As of 09:46AM EST. Market open.
Advertisement
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2022)Next Year (2023)
No. of Analysts6566
Avg. Estimate-0.51-0.47-2.11-1.73
Low Estimate-0.57-0.5-2.16-1.98
High Estimate-0.47-0.42-2.06-1.13
Year Ago EPS-0.35-0.42-1.56-2.11
Revenue EstimateCurrent Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2022)Next Year (2023)
No. of Analysts6566
Avg. Estimate6.77M6.86M43.94M24.72M
Low Estimate4M2M41.15M8M
High Estimate7.91M15M45.1M60M
Year Ago Sales20.96M20.95M77.88M43.94M
Sales Growth (year/est)-67.70%-67.30%-43.60%-43.70%
Earnings History12/30/20213/30/20226/29/20229/29/2022
EPS Est.-0.36-0.46-0.55-0.59
EPS Actual-0.35-0.42-0.59-0.59
Difference0.010.04-0.040
Surprise %2.80%8.70%-7.30%0.00%
EPS TrendCurrent Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2022)Next Year (2023)
Current Estimate-0.51-0.47-2.11-1.73
7 Days Ago-0.51-0.47-2.11-1.73
30 Days Ago-0.57-0.53-2.17-1.88
60 Days Ago-0.6-0.55-2.22-2.44
90 Days Ago-0.61-0.52-2.23-2.45
EPS RevisionsCurrent Qtr. (Dec 2022)Next Qtr. (Mar 2023)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days4444
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNGMIndustrySector(s)S&P 500
Current Qtr.-45.70%N/AN/AN/A
Next Qtr.-11.90%N/AN/AN/A
Current Year-35.30%N/AN/AN/A
Next Year18.00%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A
Advertisement
Advertisement